Chase AIPricingFAQs
Display currency
Loading news…

Editas Medicine

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Cambridge, Massachusetts, United States Founded 2013 251-500 employees For Profit

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
326
Ticker
EDIT
NASDAQ
Patents
146
10 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
EDIT
Exchange
NASDAQ
IPO date
Feb 3, 2016
Raised at IPO
$94.4M
Valuation at IPO
$571M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Active products
23
Patents granted
146
Trademarks
10
Top patent class
Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
IT spend
$3.12M

Company Info

Founded
2013
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
Founders
5
News articles
469
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Founded
Exit date
Feb 3, 2016

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.8
Trend (30d)
-2.4
Trend (90d)
4.4
Last leadership hire
May 12, 2025
Last layoff mention
Sep 2, 2025

Key People at Editas Medicine

CEO
EVP, CTO and CBO
Chief Scientific Officer & Executive Vice-President
Executive Vice President & Chief Scientific Officer
Chief Financial Officer
Executive Vice President & General Counsel
Vice President, Lead Discovery
326
professional contacts at Editas Medicine
Contact execs at Editas Medicine

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Editas Medicine

Loading news…

FAQs about Editas Medicine

People who checked this page also checked these

Browse the full Acquirezy directory.
Editas Medicine - Company Profile, Full Acquisitions List, Funding and Investments